MedPAC finalizes recommendations for Part B drug payment policy

AHA News Now

The Medicare Payment Advisory Commission yesterday finalized a package of recommendations for Congress aimed at reducing the rapid growth in Part B drug spending. The proposals would require all Part B drug manufacturers to submit Average Sales Price data; reduce Wholesale Acquisition Cost-based payment... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA further delays effective date of final rule on 340B drug ceiling prices

AHA News Now

The Health Resources and Services Administration today delayed to May 22 the effective date of its final rule on 340B drug ceiling prices and civil monetary penalties for manufacturers, and invited comments on whether a delay to Oct. 1 would be more appropriate. The rule was set to take effect March 21... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, regulation, drug prices

AHA Stat blog: Congress should protect the 340B program

AHA News Now

“Congress should preserve the 340B Drug Pricing Program and protect patients and communities,” writes AHA Executive Vice President Tom Nickels in an AHA Stat blog post. He notes, “Every day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for... read more

Topic: Advocacy and Public Policy
Tags: 340B, Drug Pricing Program, drug prices

Preserve the 340B program

Blog

Every day, we see stories about the exorbitant costs of prescription drugs and the serious challenges they pose for individuals and the entire health care system.

One program that has a 25-year track record of improving access to medications and health care services for people in vulnerable communities... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA delays effective date of final rule on 340B drug ceiling prices to March 21

AHA News Now

The Health Resources and Services Administration today delayed, in accordance with a recent White House memorandum, the effective date of its final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program from March 6 to March 21. “The temporary delay in... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation

340B omnibus guidance withdrawn

AHA News Now

The administration yesterday withdrew the Health Resources and Services Administration’s pending omnibus guidance for the 340B Drug Pricing Program. “We are pleased that the Administration chose not to finalize the Health Resources and Services Administration’s guidance, which, if enacted would have... read more

Topic: Advocacy and Public Policy
Tag: 340B

HRSA issues final rule on 340B drug ceiling prices, manufacturer penalties

AHA News Now

The Health Resources and Services Administration today released a final rule on drug ceiling prices and civil monetary penalties for manufacturers in the 340B Drug Pricing Program. Required by the Affordable Care Act, the rule amends Section 340B of the Public Health Service Act to impose monetary... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation, drug prices

AHA calls proposed rule on 340B dispute resolution process 'an important first step'

AHA News Now

The Health Resources and Services Administration’s proposed rule that would establish an administrative dispute resolution process for the 340B Drug Pricing Program “is an important first step for 340B hospitals and clinics that have been overcharged for drugs purchased through the program,” but there are... read more

Topic: Advocacy and Public Policy
Tags: 340B, regulation

AHA expresses support for Closing Loopholes for Orphan Drugs Act

AHA News Now

The AHA today expressed support for the Closing Loopholes for Orphan Drugs Act (H.R. 6174), bipartisan legislation that would limit the “orphan drug” exclusion for 340B Drug Pricing Program rural and cancer hospitals. Specifically, the legislation would allow 340B critical access hospitals, sole community... read more

Topic: Advocacy and Public Policy
Tag: 340B

Reminder: 2018 essential community provider applications due Oct. 15

AHA News Now

Hospitals that serve predominantly low-income, medically-underserved individuals may submit an application to the Centers for Medicare & Medicaid Services through Oct. 15 to add their facility to the Essential Community Provider list for the 2018 Health Insurance Marketplaces. Eligible hospitals include... read more

Topic: Advocacy and Public Policy
Tags: 340B, Coverage, rural, Critical Access Hospitals, RRC

Keyword Search

Date